Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.572 USD | -7.74% | +18.18% | +109.52% |
04-17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
04-17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+109.52% | 39.09M | |
+64.23% | 62.59B | |
-2.31% | 41.18B | |
+45.21% | 40.29B | |
-8.29% | 27.9B | |
+11.97% | 26.21B | |
-21.16% | 19.09B | |
+7.54% | 13.08B | |
+27.17% | 12.05B | |
+25.72% | 12.26B |
- Stock Market
- Equities
- BCLI Stock
- News Brainstorm Cell Therapeutics Inc.
- BrainStorm Cell Therapeutics Says US FDA Advisory Panel to Review NurOwn Biologics License Application on Sept. 27